Hyperpolarized 13C spectroscopic imaging informs on hypoxia-inducible factor-1 and myc activity downstream of platelet-derived growth factor receptor.
Hyperpolarized 13C spectroscopic imaging informs on hypoxia-inducible factor-1 and myc activity downstream of platelet-derived growth factor receptor.
复制标题
DOI:
10.1158/0008-5472.can-10-0883
复制
发表时间:
2010-10-01
期刊:
影响因子:
11.2
通讯作者:
Ronen SM
中科院分区:
文献类型:
--
作者:
Dafni H;Larson PE;Hu S;Yoshihara HA;Ward CS;Venkatesh HS;Wang C;Zhang X;Vigneron DB;Ronen SM
The recent development of hyperpolarized 13C magnetic resonance spectroscopic imaging (MRSI) provides a novel method for in-vivo metabolic imaging with potential applications for detection of cancer and response to treatment. Chemotherapy-induced apoptosis was shown to decrease the flux of hyperpolarized 13C-label from pyruvate to lactate due to depletion of NADH, the coenzyme of lactate dehydrogenase (LDH). In contrast, we show here that in PC-3MM2 tumors, inhibition of platelet-derived growth factor receptor with imatinib reduces the conversion of hyperpolarized pyruvate to lactate by lowering the expression of LDH itself. This was accompanied by reduced expression of vascular endothelial growth factor and glutaminase, and is likely mediated by reduced expression of their transcriptional factors hypoxia-inducible factor-1 and c-Myc. Our results indicate that hyperpolarized 13C MRSI could potentially detect the molecular effect of various cell-signaling inhibitors, thus providing a radiation-free method to predict tumor response.